Please try another search
LigaChem Biosciences Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was KRW 30,420.05 million compared to KRW 5,218.65 million a year ago. Net income was KRW 11,249.83 million compared to net loss of KRW 19,765.16 million a year ago. Basic earnings per share from continuing operations was KRW 330 compared to basic loss per share from continuing operations of KRW 746 a year ago. Diluted earnings per share from continuing operations was KRW 328. Basic earnings per share was KRW 330 compared to basic loss per share of KRW 746 a year ago. Diluted earnings per share was KRW 328. For the nine months, sales was KRW 92,229.53 million compared to KRW 24,958.09 million a year ago. Net income was KRW 13,219.19 million compared to net loss of KRW 57,551.95 million a year ago. Basic earnings per share from continuing operations was KRW 391 compared to basic loss per share from continuing operations of KRW 2,179 a year ago. Diluted earnings per share from continuing operations was KRW 388. Basic earnings per share was KRW 391 compared to basic loss per share of KRW 2,179 a year ago. Diluted earnings per share was KRW 388.
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Total Revenue | 30420.05 | 30753.65 | 31055.84 | 9187.55 |
Gross Profit | 26753.41 | 26556.26 | 27273.25 | 4996.22 |
Operating Income | 516.98 | -10590.22 | 2861.49 | -25192.53 |
Net Income | 11249.83 | -7445.22 | 9414.57 | -16151.62 |
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Total Assets | 727145.42 | 739329.06 | 765096.75 | 189502.18 |
Total Liabilities | 89836.55 | 114345.06 | 137358.64 | 41280.91 |
Total Equity | 637308.87 | 624984 | 627738.11 | 148221.27 |
Period Ending: | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -22630.29 | -20091.4 | 106640.09 | -17201.6 |
Cash From Investing Activities | -432.7 | -372641.63 | -73223.01 | 6819.12 |
Cash From Financing Activities | -113.71 | 3303.15 | 469748.85 | 253.92 |
Net Change in Cash | -23358.33 | -389330.91 | 503279.68 | -10604.38 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review